QTTB (Q32 Bio) Short-Term Debt to Capital
The Q32 Bio Inc. (QTTB) price chart reflects dynamics driven by the development of advanced targeted biologics and interleukin inhibitors, with the metric standing at 0.01. The business focuses on treating innate immunity pathologies within the global immunology market. However, geopolitical tensions and sanctions are severely hindering the logistics of biomaterials, complicating the execution of large-scale clinical trials for new drugs.
Analytical breakdowns for Q32 Bio Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Q32 Bio
The short-term debt-to-equity ratio measures the proportion of liabilities maturing within one year relative to shareholders' equity, reflecting current financial stability and liquidity risk. For Q32 Bio Inc. (QTTB), amid fierce competition with pharma behemoths, the short-term leverage chart serves as an indicator of the company's ability to fund development without a critical debt burden, determining the fundamental viability of the business.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV - Short-Term Debt to Equity|Short-Term Indebtedness to Equity Septerna Pharma (SEPN)|PVLA (Pieris Pharmaceuticals) - Short-Term Debt to Equity Ratio|SVRA (savarapharma.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio RIGL|ANAB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ATXS|Short-Term Debt to Equity ENGN (enGene Corp)|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Coefficient Aerovate Therapeutics, Inc. (JBIO)|ACRS - Short-Term Debt to Equity|Current Liabilities to Capital Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|Cabaletta Bio Inc - Ratio of Short-Term Indebtedness to Capital|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|theratech.com (THTX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Avalo Therapeutics (AVTX)|Eledon Pharmaceuticals Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital AGEN (Agenus Inc)|CLYM - Short-Term Debt to Equity Ratio|ZURA: Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient atyrpharma.com ATYR|adagene.com (ADAG) - Short-Term Debt to Equity|Short-Term Indebtedness to Equity Ikena Oncology IMA|Short-Term Debt to Equity Ratio STTK|EQ (Equillium Bio) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio CNTB (Connect Biopharma)|Short-Term Loans to Capital Ratio IMUX|Short-Term Debt to Capital ATRA (Atara Bio)|InflaRx NV - Short-Term Debt to Equity|XFOR - Short-Term Debt to Equity|Current Liabilities to Equity ACET|CELU: Short-Term Debt to Capital|inmunebio.com - Ratio of Short-Term Indebtedness to Capital|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Short-Term Debt to Capital Kezar Life Sciences Inc.|Short-Term Debt to Equity SAB Biotherapeutics, Inc (SABS)|AKTX (Akari Therapeutics, Plc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Enlivex Therapeutics Ltd. ENLV|GOVX - Short-Term Debt to Equity Ratio|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|XTL Bio - Ratio of Short-Term Indebtedness to Capital|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|HCW Biologics Inc (HCWB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|Short-Term Debt to Equity Ratio aimimmuno.com AIM|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI - Short-Term Debt to Equity Ratio|XRTX: Short-Term Debt to Equity Ratio|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio INDP|SCNI (Scinai) - Short-Term Debt to Capital|Current Liabilities to Capital CalciMedica Corp CALI|Short-Term Debt to Equity Affimed (AFMD)|allakos.com (ALLK) - Short-Term Indebtedness to Equity|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|IGM Biosciences Inc. - Short-Term Debt to Equity|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD (thirdharmonicbio.com) - Short-Term Debt to Equity